Sperm-Derived SPANX-B Is a Clinically Relevant Tumor Antigen That Is Expressed in Human Tumors and Readily Recognized by Human CD4+ and CD8+ T Cells
Open Access
- 15 March 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 15 (6), 1954-1963
- https://doi.org/10.1158/1078-0432.ccr-08-1290
Abstract
Purpose: The sperm-derived SPANX family proteins can be found expressed in human tumors. Here, we aimed to perform a comprehensive study to evaluate immunotherapeutic relevance of one of its members, SPANX-B. We wanted to test its expression pattern in human tumors and to evaluate CD4+ and CD8+ T-cell responses in healthy humans after in vitro immunizations. Experimental Design: Expression of SPANX-B in human malignancies, including a multitumor tissue array of 145 primary tumors, was assessed using reverse transcription-PCR, Western blotting, and immunohistochemical analysis. T-cell immunogenicity and immunodominant epitopes of SPANX-B were studied using in vitro immunizations of healthy human donor-derived leukocytes. Results: SPANX-B was abundantly expressed in melanoma and carcinomas of lung, ovary, colon, and breast. In melanoma, tissue array data indicated that it was expressed in advanced and metastatic disease. Unlike most tumor-associated antigens, SPANX-B was an immunogenic antigen that was recognized by circulating T-cell precursors in healthy humans. Importantly, these T cells were readily expanded to generate SPANX-B-specific helper CD4+ and cytolytic CD8+ T cells that recognized unique immunodominant epitopes: at least one HLA-DR-restricted Pep-9 epitope (SPANX-B12-23) and two HLA-A2-restricted Pep-2 and Pep-4 epitopes (SPANX-B23-31 and SPANX-B57-65, respectively). CD8+ T cells were fully functional to recognize and lyse HLA-A2-expressing tumors, including primary human melanomas. Conclusions: SPANX-B is an immunogenic sperm-derived antigen that is expressed in several human tumors. SPANX-B is also efficiently recognized by the human T-cell immune arm, indicating its significant value for the development of protective and therapeutic cancer vaccines.Keywords
This publication has 20 references indexed in Scilit:
- Combined high-resolution array-based comparative genomic hybridization and expression profiling of ETV6/RUNX1-positive acute lymphoblastic leukemias reveal a high incidence of cryptic Xq duplications and identify several putative target genes within the commonly gained regionLeukemia, 2007
- Evolutionary Diversification of SPANX-N Sperm Protein Gene Structure and ExpressionPLOS ONE, 2007
- Hominoid-specific SPANXA/D genes demonstrate differential expression in individuals and protein localization to a distinct nuclear envelope domain during spermatid morphogenesisMolecular Human Reproduction, 2006
- Expression of SpanX mRNA in testicular germ cell tumorsHuman Cell, 2006
- Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signaturePigment Cell Research, 2006
- Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responsesBlood, 2006
- Expression of SpanX proteins in normal testes and in testicular germ cell tumoursInternational Journal of Andrology, 2006
- Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27Genome Research, 2005
- Genomic Organization, Incidence, and Localization of the SPAN-X Family of Cancer-Testis Antigens in Melanoma Tumors and Cell LinesClinical Cancer Research, 2004
- Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignanciesBlood, 2003